Quantcast Pharmaceutical Industry News - Congoo
 
 
Log In
  COMPLETE INDUSTRY LIST >> PHARMACEUTICAL INDUSTRY    Get our Pharmaceutical Industry daily Briefing     
Accounting
Advertising industry
Aerospace & defense
Aerospace related
Agriculture
Airline industry
ASP
Automotive industry
Banking
Biological sciences
Biotech
Blogging
Book publishing
Broadcasting industry
Business related
Cable industry
Cancer
Charities
Chemicals industry
Clothing industry
Commodities
Communications equipment
Computer games
Computer security
Construction
Corporate finance
Corporate governance
Crime & Punishment
CRM
Database industry
Derivatives
Developer
Digital television
E-commerce
Economics
Emerging markets
Energy
Engineering Industry
Engineering General
Enterprise computing
Entrepreneur
Environment
Equity markets
European business
Fed watch
Finance news
Firearms industry
Food industry
Forex markets
Fund management
Genetics
GMO
Graphics industry
Handhelds
Healthcare
Hospitality industry
Human resources
Human rights
Human sciences
Imaging equipment
Insurance industry
Internet consultancies
Internet Europe
Internet news
IP and patents
IPO
Java
Job markets
Journalism
Knowledge management
Law
Law related
Leisure goods
Linux
Logistics
Macintosh
Management
Marketing
Media
Medical
Mergers & acquisitions
Metals industry
Mining and metals
Mobile industry
Mortgage industry
Movie business
Music business
Mutual funds
Nanotechnology
Newspaper publishing
Oil & gas
Online banking
Online broker
Online content
Online information
Online legal issues
Online marketing
Online portals
Open source
Outsourcing
Packaging & paper
Packaging related
Paper
PC industry
PC software
Personal data privacy
Personal finance
Personal technology
Pharmaceutical Industry
Physical Sciences
Plastics industry
Police
Public health
Real Estate industry
Religion
Retail investor
Retail sector
RFID
Robotics
RSS
Science
Securities industry
Semiconductor industry
Shipping industry
Silicon Valley
Small business
Software downloads
Space science
Steelmaking
Stock Exchanges
Stockwatch
Tech stocks
Technology
Technology news
Telecom industry
Textiles
Textiles related
Tobacco industry
Trade
Transportation industry
Transportation related
Travel industry
UK law
US education
US immigration
US politics
US security
US social policy
Utilities News
Venture Capital
Web developer
Web services
Webmaster tips
Website owner
Windows OS
Wireless sector
XML & metadata
 
 



Roche first-half sales hit by strong Swiss franc   - 6 Hours ago
6:50am BST BASEL (Reuters) - Swiss drugmaker posted a slight fall in sales in the first half, as the strong Swiss franc put the brakes on solid growth of its breast cancer medicines. The world's largest
all 3 news articles >>
  
    



Salix Pharmaceuticals Announces 2Q2014 Financial Results Conference Call and Webcast   - 80 Minutes ago
RALEIGH, N.C.--(BUSINESS WIRE)-- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will report second quarter 2014 financial results following the close of the U.S. financial
  
    




GSK asks European regulator to OK malaria shot   - 74 Minutes ago
LONDON -- Pharma giant GSK said Thursday it is submitting its malaria vaccine for regulatory approval to the European Medicines Agency. The experimental shot is the most advanced candidate vaccine for
  
    



Alexion Reports Second Quarter 2014 Results   - 75 Minutes ago
- Soliris ® (eculizumab) Net Product Sales Increased 38 Percent to $512.5 Million - - EU Marketing Authorization Application for Asfotase Alfa Accepted by EMA; Accelerated Assessment
  
    



Agenus Reports Second Quarter 2014 Financial Results   - 72 Minutes ago
Agenus to host conference call beginning at 11 a.m. ET today LEXINGTON, Mass.--(BUSINESS WIRE)--Jul. 24, 2014-- Agenus Inc. (NASDAQ:AGEN), an immuno-oncology company developing a portfolio of checkpoint
  
    



BRIEF-Pharmaceutical firm Guangxi Wuzhou Zhongheng's H1 profit up, plans buyout   - 72 Minutes ago
12:02pm BST July 24 (Reuters) - Guangxi Wuzhou Zhongheng Group Co Ltd * Says H1 net profit up 31 percent y/y at 490.3 million yuan ($79.15 million) * Says plans to set up healthcare buyout fund with
  
    


Ernst & Young - The right transaction Sponsored
No matter what the size of your company, where it is located or the business you are in, transactions can help your company grow, prosper or reinvent itself. The Ernst and Young Transaction professionals can play a critical role at every step of the deal lifecycle.  Learn More



UPDATE 1-Slovenian drug firm Krka's first-half profit rises   - 72 Minutes ago
11:52am BST (Adds quotes, details, background) LJUBLJANA, July 24 (Reuters) - Slovenian pharmaceutical company Krka said first-half group net profit rose 6 percent year-on-year to 106.6 million euros
  
    



Lilly beats forecasts, helped by cost controls   - 72 Minutes ago
11:48am BST July 24 (Reuters) - Eli Lilly and Co's quarterly revenue plunged due to generic competition for its Cymbalta depression drug and its Evista osteoporosis treatment, but overall results beat
  
    



UPDATE 1-Lilly beats forecasts, helped by cost controls   - 68 Minutes ago
Eli Lilly and Co's quarterly revenue plunged due to generic competition for its Cymbalta depression drug and its Evista osteoporosis treatment, but earnings beat forecasts, helped by cost controls. (Adds
  
    


Your sponsored post can go right here! Sponsored

Congoo’s B2B information portal now receives over 1 million visits per month.  Congoo provides a highly influential audience comprehensive news and information within their industry.  Reach a coveted audience of senior executives, affluent males and opinion leaders. Get the Media Kit




Miracle Cures Spur Demand for Access to $1,000 Hepatitis Pill   - 6 Hours ago
July 23 (Bloomberg) -- The powerful new hepatitis C drug that sent Gilead Sciences Inc.’s sales soaring last quarter is doing the same for the hopes of millions of patients. Sandra Cabrera and Ted Tabor
  
    



BRIEF-Roche CEO-"too early" to make a decision on crenezumab   - 6 Hours ago
Roche Holding AG : * CEO says "too early" to make a decision on whether to take alzheimer's drug
  
    



Research and Markets: Global Nicotine Gum Market 2014-2018: Key Vendors are GlaxoSmithKline,   - 71 Minutes ago
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc. Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes. Markets are closed on certain holidays. Stock
  
    


American Express takes you places Sponsored
The Preferred Rewards Gold Card takes you places. And shows you’ve arrived. Enjoy Gold Card benefits and access while you earn travel rewards fast. Earn 10,000 Membership Rewards® bonus points redeemable for rewards after your first purchase.  Learn More



Roche’s Profit Falls on Franc Strength as New-Drug Sales Climb   - 6 Hours ago
July 24 (Bloomberg) -- Roche Holding AG’s first-half profit fell 7 percent as the strength of the Swiss franc offset rising sales of the drugmaker’s new cancer medicines. Net income fell 7 percent to
  
    



Eli Lilly EPS Estimates Improved In Past Month   - 12 Hours ago
Analysts have become increasingly bullish on Eli Lilly in the month leading up to the company’s second-quarter earnings announcement scheduled for Thursday, July 24, 2014. The consensus earnings per share
  
    



An Expert Civil Surgeon at Santa Monica Pediatrics and Adult Medicine can Make all   - 12 Hours ago
SOURCE Santa Monica Pediatrics & Adult Medicine When seeking a better life for your family, don't take a chance on medical care - instead, count on the expert civil surgeons at Santa Monica Pediatrics
  
    



INNATE PHARMA : Completion of target enrollment in the phase II EffiKIR trial   - 6 Hours ago
Data on primary efficacy endpoint Leukemia-Free Survival expected end of 2015 MARSEILLE, France, July 24, 2014 (GLOBE NEWSWIRE) -- Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH),
  
    



J&J’s Immunology Chief on Investing at the Crossroads of the Microbiome   - 79 Minutes ago
When Roger Pomerantz, the CEO of Cambridge, MA-based Seres Health said last week that he’s preparing to take his company public off of a promising, early study, it wasn’t just the natural next step for
  
    



Advanced Biological Laboratories (ABL) and Roche Diagnostics International Renew   - 81 Minutes ago
[July 24, 2014] LUXEMBOURG --(Business Wire)-- Advanced Biological Laboratories (ABL) today announced the renewal of a non-exclusive collaboration agreement with Roche Diagnostics International
  
    



Boston Scientific launches POLARIS imaging system   - 74 Minutes ago
– Boston Scientific Corporation (NYSE: BSX) has initiated full commercial launch of the new POLARIS™ Imaging System. This system will support the Boston Scientific family of intravascular ultrasound (IVUS)
all 4 news articles >>
  
    



MorphoSys, Galapagos advance joint antibody programme in inflammatory diseases into   - 6 Hours ago
MorphoSys AG and Galapagos NV announced that the first programme from their strategic alliance has advanced into preclinical development. MOR106 was realised based on a novel Galapagos target and MorphoSys'
  
    



06:35 Roche first half net profit hit by diagnostics writedown   - 6 Hours ago
This figure included impairment charges of 414 million francs related to intangible assets in tissue diagnostics. Solid sales of Roche's breast cancer medicines and tight cost control helped the Swiss
  
    



Panacea Biotec plans to raise up to $42M   - 6 Hours ago
Delhi-based drug maker Panacea Biotec Ltd is looking to raise up to Rs 250 crore ($42 million) by way of issue of securities as per a company statement. The company’s board is meeting on August 1, 2014,
  
    



Strides Arcolab gets USFDA approval t...   - 6 Hours ago
NEW DELHI: Pharmaceutical firm Strides Arcolab has received the regulatory approval to market Tacrolimus capsules in the US market. The capsule is an immuno-suppressant used for preventing organ rejection
  
    



Ipca Labs halts shipments to US after Food and Drug Administration concerns   - 6 Hours ago
MUMBAI: said it has temporarily suspended shipments to the United States from one of its drug ingredient manufacturing plants after the expressed concerns regarding the unit. The shipment halt from
  
    



Shire, ArmaGen ink worldwide licensing pact for enzyme replacement therapy   - 8 Hours ago
Shire plc, the global specialty biopharmaceutical company, and US-based privately held biotechnology company, ArmaGen announced a worldwide licensing and collaboration agreement for AGT-182, an investigational
  
    
*Votes may take up to 30 minutes to influence article rank order
Featured Members
Melissa Lowenstein Melissa Lowenstein
Pharma Industry
Shannon Peryea Shannon Peryea
Vice President, Executive Recruiting
Pharma Industry
John Caminis John Caminis
Vice President Clinical Development
Pharma Industry
Frank Forney Frank Forney
Pharma Industry

  Add your Profile
  View more profiles

   




 
 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2014 Congoo.com. All Rights Reserved.